Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.

Michelle RosenzwajgRoberta LorenzonPatrice CacoubHang Phuong PhamFabien PitoisetKarim El SoufiClaire RIbetClaude BernardSelim AractingiBeatrice BannevilleLaurent BeaugerieFrancis BerenbaumJulien ChampeyOlivier ChazouilleresChristophe CorpechotBruno FautrelArsenne MekinianElodie RegnierDavid SaadounJoe-Elie SalemJérémie SellamPhilippe SeksikAnne Daguenel-NguyenValérie DopplerJéremie MariauEric VicautDavid Klatzmann

Published in: Annals of the rheumatic diseases (2018)

NCT01988506.

Keyphrases

low dose
clinical trial
minimally invasive
high dose
study protocol
phase ii
open label
double blind